Single dose dipyrone for acute renal colic pain

Area of Science:

• Pharmacology
• Pain Management
• Clinical Trials

Background:

• Renal colic causes severe pain requiring potent analgesics.
• Dipyrone is a widely used non-opioid analgesic, but carries risks like agranulocytosis in some regions.
• Evaluating dipyrone's efficacy and safety for renal colic is crucial due to its varied regulatory status.

Purpose of the Study:

• To quantitatively assess the analgesic effectiveness of single-dose dipyrone in adults with moderate to severe renal colic.
• To evaluate the adverse effects associated with single-dose dipyrone administration for renal colic.

Main Methods:

• Systematic review of published randomized controlled trials (RCTs) identified through major electronic databases up to January 2000.
• Inclusion criteria focused on double-blind RCTs in adults with moderate to severe renal colic, comparing dipyrone to a control.
• Data on pain relief (at least 50% reduction) and adverse events from single doses were extracted and analyzed.

Main Results:

• Eleven studies with 1053 patients (550 on dipyrone) were included; however, limited data precluded robust statistical pooling.
• Efficacy estimates were derived from available trial data, indicating dipyrone's comparable pain relief to other analgesics.
• Common adverse effects for intravenous dipyrone included dry mouth and somnolence; injection site pain was also noted. Safety data was insufficient for comprehensive analysis.

Conclusions:

• Single-dose dipyrone shows comparable analgesic efficacy to other agents for renal colic, with IV administration being more effective than IM.
• Intramuscular dipyrone was less effective than diclofenac 75 mg, and combination with antispasmolytics did not enhance efficacy.
• While common side effects like dry mouth and somnolence were observed with IV dipyrone, agranulocytosis was not reported in the reviewed studies.